Latest Articles about LLY

Oncogenex to Advance OGX-427 Development - Analyst Blog

Zacks Equity Research — Sat, 25 May 2013 00:27:52 Z

OncoGenex Pharmaceuticals, Inc. ( OGXI ) recently announced that it is looking to move its oncology candidate, OGX-427, into a phase II study (Cedar: n~140). The study will evaluate OGX-427

Priority FDA Review for Celgene's Abraxane - Analyst Blog

Zacks Equity Research — Fri, 24 May 2013 19:28:02 Z

Celgene Corporation ( CELG ) recently announced that the US Food and Drug Administration (FDA) will review the supplemental New Drug Application (sNDA) for cancer drug Abraxane on a

Amgen to Set Up JV in China - Analyst Blog

Zacks Equity Research — Wed, 15 May 2013 01:05:29 Z

Amgen ( AMGN ) recently announced its intention to set up a joint venture (JV) in China with Zhejiang Beta Pharma Co., Ltd. The JV will focus on the commercialization of Amgen's

Lilly Scraps Oncology Candidate - Analyst Blog

Zacks Equity Research — Mon, 13 May 2013 20:16:44 Z

Eli Lilly and Company ( LLY ) recently announced a pipeline setback with its oncology candidate, enzastaurin, failing in a phase III study. Eli Lilly was evaluating enzastaurin as a

Eli Lilly and Company (LLY) Ex-Dividend Date Scheduled for May 14, 2013

NASDAQ.com News — Mon, 13 May 2013 15:39:06 Z

Eli Lilly and Company ( LLY ) will begin trading ex-dividend on May 14, 2013. A cash dividend payment of $0.49 per share is scheduled to be paid on June 10, 2013. Shareholders who purchased LLY

For Farmers, Rise in Suicide Rate Is Old News

Justin Rohrlich — Wed, 08 May 2013 22:55:00 Z

The recent news from the Centers for Disease Control and Prevention that more Americans now die of suicide than in car accidents made headlines . Though reasons for suicide are extremely

Earnings Preview: AmerisourceBergen - Analyst Blog

Zacks Equity Research — Thu, 25 Apr 2013 01:10:50 Z

AmerisourceBergen ( ABC ) is set to report second quarter 2013 results on Apr 25, 2013. Last quarter, the company reported in-line results for the first quarter. Let's see how things are

Lilly Earnings Better Than Expected - Analyst Blog

Zacks Equity Research — Wed, 24 Apr 2013 17:14:17 Z

Eli Lilly & Company ( LLY ) reported first quarter 2013 adjusted earnings per share of $1.14, well above the Zacks Consensus Estimate of $1.05 and 24% above the year-ago earnings of

Will Eli Lilly Beat Earnings in 1Q? - Analyst Blog

Zacks Equity Research — Wed, 24 Apr 2013 01:11:25 Z

We expect Eli Lilly and Company ( LLY ) to beat earnings expectations when it reports first-quarter 2013 results before the opening bell on Apr 24, 2013. Why a Likely Positive Surprise?

Pre-Market Earnings Report for April 24, 2013 : PG, BA, LLY, F, EMC, SO, ERIC, PX, TMO, GD, HES, NVS

NASDAQ.com News — Wed, 24 Apr 2013 00:00:04 Z

The following companies are expected to report earnings prior to market open on 04/24/2013. Visit our Earnings Calendar for a full list of expected earnings releases. Procter & Gamble

Will Amgen Beat Earnings? - Analyst Blog

Zacks Equity Research — Tue, 23 Apr 2013 01:11:30 Z

We expect Amgen Inc. ( AMGN ) to beat earnings expectations when it reports first-quarter 2013 results after the closing bell on Apr 23, 2013. Why a Likely Positive Surprise? Our

Eli Lilly in Alzheimer's Deal - Analyst Blog

Zacks Equity Research — Tue, 23 Apr 2013 00:11:11 Z

Eli Lilly and Company ( LLY ) recently announced the acquisition of a couple of investigational positron emission tomography (PET) tracers from Siemens Medical Solutions USA, Inc. The

Bristol-Myers Likely to Report In Line Earnings - Analyst Blog

Zacks Equity Research — Tue, 23 Apr 2013 00:09:40 Z

We expect Bristol-Myers Squibb Company ( BMY ) to report in line first-quarter 2013 results before the opening bell on Apr 25. Factors to Consider this Quarter The genericization of

Forest Labs Likely to Miss 4Q Earnings - Analyst Blog

Zacks Equity Research — Mon, 22 Apr 2013 20:11:44 Z

We expect Forest Laboratories Inc. ( FRX ) to miss earnings expectations when it reports fourth-quarter fiscal 2013 results on Apr 23, before the opening bell. Forest Labs' fiscal year ends

Biogen: Will it Miss Earnings Again? - Analyst Blog

Zacks Equity Research — Mon, 22 Apr 2013 18:12:33 Z

We expect Biogen Idec, Inc. ( BIIB ) to report lower-than-expected earnings when it releases its first-quarter 2013 results before the opening bell on Apr 25. We note that Biogen had missed